Sagimet Biosciences (NASDAQ:SGMT) Given Buy Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a report published on Tuesday morning,Benzinga reports. HC Wainwright currently has a $32.00 price objective on the stock. A number of other research analysts have also recently weighed in on the stock. UBS Group initiated coverage on shares of […]
